Payment overview · 2025
General Payments
We did not find matching Open Payments records for this doctor in the selected program year.
Healthcare provider profile · identity verified
Internal Medicine · ASPINWALL, PA · NPI 1386039857
Verified facts
We did not find matching Open Payments records for this doctor in 2025.
These records do not establish that a payment influenced prescribing or medical care.
Payment overview · 2025
We did not find matching Open Payments records for this doctor in the selected program year.
Separate record types
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Analysis 1 · Payment-linked products
No payment-linked product analysis is available because no matching General Payment records were found for the selected year.
There is no explicit payment-product set available for a Part D comparison.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
There is no payer-company set available for this comparison.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 543 | 161 |
| Levothyroxine Sodium | Levothyroxine Sodium | 368 | 102 |
| Amlodipine Besylate | Amlodipine Besylate | 348 | 100 |
| Losartan Potassium | Losartan Potassium | 348 | 107 |
| Lisinopril | Lisinopril | 254 | 68 |
| Hydrochlorothiazide | Hydrochlorothiazide | 241 | 66 |
| Simvastatin | Simvastatin | 227 | 68 |
| Omeprazole | Omeprazole | 226 | 73 |
| Gabapentin | Gabapentin | 223 | 52 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 171 | 61 |
| Alprazolam | Alprazolam | 160 | 41 |
| Metformin Hcl | Metformin Hcl | 148 | 44 |
| Eliquis | Apixaban | 147 | 34 |
| Zolpidem Tartrate | Zolpidem Tartrate | 147 | 29 |
| Metoprolol Succinate | Metoprolol Succinate | 146 | 39 |
| Pantoprazole Sodium | Pantoprazole Sodium | 146 | 45 |
| Sertraline Hcl | Sertraline Hcl | 146 | 40 |
| Furosemide | Furosemide | 135 | 49 |
| Famotidine | Famotidine | 130 | 45 |
| Ozempic | Semaglutide | 123 | 22 |
| Fluticasone Propionate | Fluticasone Propionate | 121 | 38 |
| Lorazepam | Lorazepam | 117 | 35 |
| Metoprolol Tartrate | Metoprolol Tartrate | 113 | 38 |
| Citalopram Hbr | Citalopram Hydrobromide | 102 | 27 |
| Escitalopram Oxalate | Escitalopram Oxalate | 102 | 32 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 102 | 19 |
| Tamsulosin Hcl | Tamsulosin Hcl | 101 | 33 |
| Clonazepam | Clonazepam | 100 | 15 |
| Potassium Chloride | Potassium Chloride | 96 | 28 |
| Trazodone Hcl | Trazodone Hcl | 96 | 32 |
| Metformin Hcl Er | Metformin Hcl | 93 | 30 |
| Atenolol | Atenolol | 92 | 29 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 85 | 34 |
| Oxycodone Hcl | Oxycodone Hcl | 83 | 14 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 82 | 23 |
| Synthroid | Levothyroxine Sodium | 81 | 25 |
| Meloxicam | Meloxicam | 75 | 22 |
| Celecoxib | Celecoxib | 72 | 19 |
| Jardiance | Empagliflozin | 71 | 20 |
| Tramadol Hcl | Tramadol Hcl | 71 | 25 |
| Carvedilol | Carvedilol | 69 | 19 |
| Bupropion Hcl Sr | Bupropion Hcl | 58 | 15 |
| Duloxetine Hcl | Duloxetine Hcl | 58 | 15 |
| Donepezil Hcl | Donepezil Hcl | 57 | 11 |
| Xarelto | Rivaroxaban | 57 | 13 |
| Clopidogrel | Clopidogrel Bisulfate | 55 | 19 |
| Alendronate Sodium | Alendronate Sodium | 51 | 14 |
| Glipizide Er | Glipizide | 48 | 11 |
| Ibuprofen | Ibuprofen | 48 | 16 |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 47 | 13 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 45 | 19 |
| Mirtazapine | Mirtazapine | 45 | 11 |
| Spironolactone | Spironolactone | 45 | 13 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 45 | 13 |
| Methylprednisolone | Methylprednisolone | 42 | 40 |
| Allopurinol | Allopurinol | 41 | 15 |
| Bupropion Xl | Bupropion Hcl | 41 | 14 |
| Pravastatin Sodium | Pravastatin Sodium | 41 | 11 |
| Tradjenta | Linagliptin | 40 | 11 |
| Amoxicillin | Amoxicillin | 39 | 25 |
| Finasteride | Finasteride | 39 | suppressed |
| Azithromycin | Azithromycin | 38 | 35 |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 38 | suppressed |
| Ezetimibe | Ezetimibe | 38 | 13 |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 36 | 30 |
| Doxycycline Monohydrate | Doxycycline Monohydrate | 36 | 30 |
| Valsartan | Valsartan | 35 | suppressed |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 33 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 33 | suppressed |
| Ultra-Fine Short Pen Needle | Pen Needle, Diabetic | 33 | suppressed |
| Baclofen | Baclofen | 32 | suppressed |
| Jantoven | Warfarin Sodium | 32 | suppressed |
| Prednisone | Prednisone | 32 | 20 |
| Nifedipine Er | Nifedipine | 31 | suppressed |
| Bisoprolol Fumarate | Bisoprolol Fumarate | 30 | 12 |
| Buspirone Hcl | Buspirone Hcl | 30 | 12 |
| Irbesartan | Irbesartan | 30 | suppressed |
| Trulicity | Dulaglutide | 30 | suppressed |
| Warfarin Sodium | Warfarin Sodium | 30 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 29 | suppressed |
| Ropinirole Hcl | Ropinirole Hcl | 29 | suppressed |
| Dicyclomine Hcl | Dicyclomine Hcl | 28 | suppressed |
| Ibu | Ibuprofen | 28 | suppressed |
| Sumatriptan Succinate | Sumatriptan Succinate | 28 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 28 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 27 | 23 |
| Ondansetron Hcl | Ondansetron Hcl | 27 | 16 |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 27 | suppressed |
| Felodipine Er | Felodipine | 26 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 26 | 13 |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 26 | 16 |
| Montelukast Sodium | Montelukast Sodium | 25 | 11 |
| Cartia Xt | Diltiazem Hcl | 23 | suppressed |
| Cholestyramine | Cholestyramine (With Sugar) | 23 | suppressed |
| Fluoxetine Hcl | Fluoxetine Hcl | 23 | suppressed |
| Mounjaro | Tirzepatide | 23 | suppressed |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 23 | suppressed |
| Hydrocortisone | Hydrocortisone | 22 | suppressed |
| Paxlovid | Nirmatrelvir/Ritonavir | 22 | 22 |
| Glimepiride | Glimepiride | 21 | suppressed |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 21 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 20 | suppressed |
| Lansoprazole | Lansoprazole | 20 | suppressed |
| Cefuroxime | Cefuroxime Axetil | 19 | 15 |
| Ketoconazole | Ketoconazole | 19 | suppressed |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 19 | suppressed |
| Morphine Sulfate Er | Morphine Sulfate | 19 | suppressed |
| Nystatin | Nystatin | 19 | suppressed |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 19 | suppressed |
| Valsartan-Hydrochlorothiazide | Valsartan/Hydrochlorothiazide | 19 | suppressed |
| Cephalexin | Cephalexin | 18 | 13 |
| Dextroamphetamine-Amphetamine | Dextroamphetamine/Amphetamine | 18 | suppressed |
| Myrbetriq | Mirabegron | 17 | suppressed |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 17 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 17 | suppressed |
| Mupirocin | Mupirocin | 16 | 12 |
| Amiodarone Hcl | Amiodarone Hcl | 15 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 15 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 14 | suppressed |
| Carisoprodol | Carisoprodol | 14 | suppressed |
| Levetiracetam | Levetiracetam | 14 | suppressed |
| Methocarbamol | Methocarbamol | 14 | suppressed |
| Quetiapine Fumarate | Quetiapine Fumarate | 14 | suppressed |
| Terazosin Hcl | Terazosin Hcl | 14 | suppressed |
| Chlorthalidone | Chlorthalidone | 13 | suppressed |
| Fluconazole | Fluconazole | 13 | suppressed |
| Glipizide | Glipizide | 13 | suppressed |
| Hydroxychloroquine Sulfate | Hydroxychloroquine Sulfate | 13 | suppressed |
| Januvia | Sitagliptin Phosphate | 13 | suppressed |
| Anoro Ellipta | Umeclidinium Brm/Vilanterol Tr | 12 | suppressed |
| Bumetanide | Bumetanide | 12 | suppressed |
| Clobetasol Propionate | Clobetasol Propionate | 12 | suppressed |
| Diclofenac Sodium | Diclofenac Sodium | 12 | suppressed |
| Enalapril Maleate | Enalapril Maleate | 12 | suppressed |
| Nitroglycerin | Nitroglycerin | 12 | suppressed |
| Phenytoin Sodium Extended | Phenytoin Sodium Extended | 12 | suppressed |
| Premarin | Estrogens, Conjugated | 12 | suppressed |
| Topiramate | Topiramate | 12 | suppressed |
| Nortriptyline Hcl | Nortriptyline Hcl | 11 | suppressed |
| Zolmitriptan | Zolmitriptan | 11 | suppressed |
Timeline
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | — | — | — | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error